Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.

He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL, Zhu FH, Tang W, Zuo JP.

Acta Pharmacol Sin. 2014 Feb;35(2):219-29. doi: 10.1038/aps.2013.167. Epub 2013 Dec 30.


Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression.

Wu QL, Fu YF, Zhou WL, Wang JX, Feng YH, Liu J, Xu JY, He PL, Zhou R, Tang W, Wang GF, Zhou Y, Yang YF, Ding J, Li XY, Chen XR, Yuan C, Lawson BR, Zuo JP.

J Pharmacol Exp Ther. 2005 May;313(2):705-11. Epub 2005 Jan 7.


S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses.

Fu YF, Wang JX, Zhao Y, Yang Y, Tang W, Ni J, Zhu YN, Zhou R, He PL, Li C, Li XY, Yang YF, Lawson BR, Zuo JP.

J Pharmacol Exp Ther. 2006 Mar;316(3):1229-37. Epub 2005 Dec 2.


SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.

Hou LF, He SJ, Li X, Wan CP, Yang Y, Zhang XH, He PL, Zhou Y, Zhu FH, Yang YF, Li Y, Tang W, Zuo JP.

PLoS One. 2012;7(2):e32424. doi: 10.1371/journal.pone.0032424. Epub 2012 Feb 28.


Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.

Yao L, Chen HP, Ma Q.

Immunol Lett. 2014 Sep;161(1):76-80. doi: 10.1016/j.imlet.2014.05.001. Epub 2014 May 14.


Critical role of transmethylation in TLR signaling and systemic lupus erythematosus.

Tardif V, Manenkova Y, Berger M, Hoebe K, Zuo JP, Yuan C, Kono DH, Theofilopoulos AN, Lawson BR.

Clin Immunol. 2013 May;147(2):133-43. doi: 10.1016/j.clim.2013.02.018. Epub 2013 Mar 5.


Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Ryffel B, Car BD, Gunn H, Roman D, Hiestand P, Mihatsch MJ.

Am J Pathol. 1994 May;144(5):927-37.


Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.

Yamauchi M, Hashimoto M, Ichiyama K, Yoshida R, Hanada T, Muta T, Komune S, Kobayashi T, Yoshimura A.

Int Immunol. 2007 Aug;19(8):935-42. Epub 2007 Aug 16.


Fluoxetine inhibits hyperresponsive lamina propria mononuclear cells and bone marrow-derived dendritic cells, and ameliorates chronic colitis in IL-10-deficient mice.

Koh SJ, Kim JW, Kim BG, Lee KL, Im JP, Kim JS.

Dig Dis Sci. 2015 Jan;60(1):101-8. doi: 10.1007/s10620-014-3326-9. Epub 2014 Aug 22.


TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.

Pau E, Cheung YH, Loh C, Lajoie G, Wither JE.

PLoS One. 2012;7(5):e36761. doi: 10.1371/journal.pone.0036761. Epub 2012 May 4.


[Effects of different Toll-like receptor agonists on the function of T helper cells in mice].

Li X, Zhang Y, Yang B, Wu C.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Nov;31(11):141-1446. Chinese.


Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.

Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.

Arthritis Rheum. 2009 Jun;60(6):1775-84. doi: 10.1002/art.24548.


IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.

Liu Z, Bethunaickan R, Huang W, Ramanujam M, Madaio MP, Davidson A.

J Immunol. 2011 Aug 1;187(3):1506-13. doi: 10.4049/jimmunol.1004142. Epub 2011 Jun 24.


Dysregulation of T helper cell cytokines in autoimmune prone NZB x NZW F1 mice.

Lin LC, Chen YC, Chou CC, Hsieh KH, Chiang BL.

Scand J Immunol. 1995 Oct;42(4):466-72.


Soluble human CD83 ameliorates lupus in NZB/W F1 mice.

Starke C, Steinkasserer A, Voll RE, Zinser E.

Immunobiology. 2013 Nov;218(11):1411-5. doi: 10.1016/j.imbio.2013.06.002. Epub 2013 Jun 17.


Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.

Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M.

J Exp Med. 1994 Jan 1;179(1):305-10.


Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.

Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.

Arthritis Rheum. 2005 Nov;52(11):3629-38.


Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.

Graham KL, Lee LY, Higgins JP, Steinman L, Utz PJ, Ho PP.

Autoimmunity. 2010 Mar;43(2):140-55. doi: 10.3109/08916930903229239.

Items per page

Supplemental Content

Support Center